Investors

Key press releases

Key upcoming events

Key corporate presentation

Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on the Euronext Growth Paris (ticker: ALCLS).

Cellectis ADS (Nasdaq)

Ticker: CLLS

$27.7900

-2.3200 (-7.7051%)

Prev. close
30.1100
Volume
368,777
High
29.5700
Capitalization
1.181B
Last Update: 14 hours ago

Cellectis (Euronext Growth Paris)

Ticker: ALCLS

€23.0500

-1.3000 (-5.3388%)

Prev. close
24.3500
Volume
82,422
High
23.5000
Capitalization
979.375M
Last Update: 24 minutes ago

Covering research analysts

Barclays - Gena Wang

Citi - Yigal Nochomovitz

Goldman Sachs - Salveen Richter

Guggenheim - Michael Schmidt

Jefferies – Biren Amin

Jones Trading - Soumit Roy

Kempen - Ingrid Gafanhão

Ladenburg – Wangzhi Li

Oddo BHF - Martial Descoutures

Oppenheimer – Hartaj Singh

Portzamparc – Christophe Dombu

RW Baird - Madhu Kumar

Wells Fargo – Jim Birchenough

William Blair – Raju Prasad

Cellectis contact information

Simon Harnest
Investor Relations USA
+1 646 385 9008

Citibank ADR contact information

Intermediaries & Investors
US: +1 212 723 5435
UK: +44 207 500 2030

Société Générale Securities Services - Ordinary Shares contact information

Call center in English and French

Monday to Friday from 8:30am to 6pm CEST

+33 (0)2 51 85 67 89